FDA Accepts Ivonescimab BLA in NSCLC
FDA Accepts BLA for Ivonescimab Regimen in Pretreated EGFR-Mutated NSCLC
| Read More |
FDA OKs Larger Nelarabine Vial in T-Cell Leukemia and Lymphoma Populations
| Read More |
New Career Center Video:
Learn how to build and strengthen your oncology referral network with expert insights from Tarita Thomas, MD, PhD, MBA, FACRO. Watch Increasing Your Oncology Referral Network now.
| Watch Here! |
Videos
![]() Standardizing Clinical Breast Examination in Low- and Middle-Income Countries
|
![]() Durable Frontline Benefit with Zanubrutinib: Long-Term Lessons from High-Risk CLL
|
Trending
|
|
![]() Cooled Laser Focal Therapy Shows High Local Control in Prostate Cancer
|



